The Valley of Death and the California Stem Cell Agency: Luring Deep Pocket Investors
The California stem cell agency this week is tooting a $150 million horn and heralding its efforts to assist stem cell businesses with development of therapies that could ease the travails of everything from cancer to blindness.
It is all about a financial "valley of death" that can imperil biotech firms as they seek to turn research into an actual prod…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.